Naples Global Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$542K Buy
1,850
+5
+0.3% +$1.64K 0.04% 315
2025
Q4
$647K Sell
1,845
-169
-8% -$57.1K 0.05% 284
2025
Q3
$651K Buy
2,014
+1,133
+129% +$352K 0.05% 286
2025
Q2
$343K Sell
881
-60
-6% -$24.1K 0.03% 350
2025
Q1
$409K Sell
941
-799
-46% -$321K 0.04% 325
2024
Q4
$642K Buy
1,740
+480
+38% +$201K 0.06% 265
2024
Q3
$655K Buy
1,260
+120
+11% +$64.1K 0.06% 263
2024
Q2
$618K Buy
1,140
+40
+4% +$21.1K 0.06% 258
2024
Q1
$570K Buy
+1,100
New +$547K 0.06% 272

Other funds holding ELV

Naples Global Advisors's ELV Position: Q1 2026 in Review

Naples Global Advisors increased its Elevance Health (ELV) stake by 0.27% in Q1 2026, buying an estimated $1.64K and bringing the position to 1,850 shares worth $542K. The position accounts for 0.04% of the portfolio, ranked #315.

Naples Global Advisors first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. The position peaked at $655K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Naples Global Advisors held 1,850 shares of Elevance Health worth $542K as of Q1 2026.
  • Naples Global Advisors bought 5 Elevance Health shares in Q1 2026, an estimated $1.64K.
  • Elevance Health made up 0.04% of Naples Global Advisors's portfolio in Q1 2026, its #315 holding.
  • Naples Global Advisors first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
  • Naples Global Advisors's Elevance Health position peaked at $655K in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Naples Global Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.